Boston Scientific (BSX) Tops Q3 EPS by 12c
Get Alerts BSX Hot Sheet
Price: $42.04 +1.11%
EPS Growth %: +2.7%
Financial Fact:
Net income (loss) per common share - assuming dilution: 0.17
Today's EPS Names:
PKE, BYRN, HELE, More
EPS Growth %: +2.7%
Financial Fact:
Net income (loss) per common share - assuming dilution: 0.17
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.37, $0.12 better than the analyst estimate of $0.25. Revenue for the quarter came in at $2.67 billion versus the consensus estimate of $2.52 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana soars, Alignment Healthcare sinks on Medicare rating changes
- Boston Scientific names new COO, restructures into three segments
- Boston Scientific (BSX) PT Lowered to $54 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share